121 related articles for article (PubMed ID: 19523139)
1. Latisse: empirical discovery yields treatment for sparse eyelashes.
Woodson SA
Nurs Womens Health; 2009 Jun; 13(3):243-8. PubMed ID: 19523139
[No Abstract] [Full Text] [Related]
2. Bimatoprost 0.03% solution (latisse) for eyelash enhancement.
Med Lett Drugs Ther; 2009 Jun; 51(1313):43-4. PubMed ID: 19478690
[No Abstract] [Full Text] [Related]
3. Latisse (bimatoprost) for enhancement of eyelashes.
Flaharty PM; Flaharty KK; Gorman L
Insight; 2014; 39(3):24-6. PubMed ID: 25195339
[No Abstract] [Full Text] [Related]
4. Application of bimatoprost ophthalmic solution 0.03% for the treatment of eyebrow hypotrichosis: series of ten cases.
Vergilis-Kalner IJ
Dermatol Online J; 2014 Jun; 20(6):. PubMed ID: 24945645
[TBL] [Abstract][Full Text] [Related]
5. Latisse-induced periocular skin hyperpigmentation.
Priluck JC; Fu S
Arch Ophthalmol; 2010 Jun; 128(6):792-3. PubMed ID: 20547960
[No Abstract] [Full Text] [Related]
6. A retrospective review and observational study of outcomes and safety of bimatoprost ophthalmic solution 0.03% for treating eyelash hypotrichosis.
Yoelin SG; Fagien S; Cox SE; Davis PG; Campo A; Caulkins CA; Gallagher CJ
Dermatol Surg; 2014 Oct; 40(10):1118-24. PubMed ID: 25229783
[TBL] [Abstract][Full Text] [Related]
7. Company profits from side effects of glaucoma treatment.
Banaszek A
CMAJ; 2011 Oct; 183(14):E1058. PubMed ID: 21876012
[No Abstract] [Full Text] [Related]
8. My eyelashes have become very thin over the years, and I'm hopeless with mascara. Is it safe to use this new prescription product that's supposed to grow eyelashes?
Mayo Clin Health Lett; 2009 Dec; 27(12):8. PubMed ID: 20082494
[No Abstract] [Full Text] [Related]
9. Patient-reported outcomes of bimatoprost for eyelash growth: results from a randomized, double-masked, vehicle-controlled, parallel-group study.
Fagien S; Walt JG; Carruthers J; Cox SE; Wirta D; Weng E; Beddingfield FC
Aesthet Surg J; 2013 Aug; 33(6):789-98. PubMed ID: 23873891
[TBL] [Abstract][Full Text] [Related]
10. Enhancing the growth of natural eyelashes: the mechanism of bimatoprost-induced eyelash growth.
Cohen JL
Dermatol Surg; 2010 Sep; 36(9):1361-71. PubMed ID: 20384750
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of bimatoprost solution 0.03% topical application in patients with chemotherapy-induced eyelash loss.
Ahluwalia GS
J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S73-6. PubMed ID: 24326568
[TBL] [Abstract][Full Text] [Related]
12. Revisiting the Safety of Prostaglandin Analog Eyelash Growth Products.
Steinsapir KD; Steinsapir SMG
Dermatol Surg; 2021 May; 47(5):658-665. PubMed ID: 33625141
[TBL] [Abstract][Full Text] [Related]
13. Topical bimatoprost 0.03% and iatrogenic eyelid and orbital lipodystrophy.
Sira M; Verity DH; Malhotra R
Aesthet Surg J; 2012 Sep; 32(7):822-4. PubMed ID: 22942109
[TBL] [Abstract][Full Text] [Related]
14. Prevention of dermatologic side effects of bimatoprost 0.03% topical therapy.
Centofanti M; Oddone F; Chimenti S; Tanga L; Citarella L; Manni G
Am J Ophthalmol; 2006 Dec; 142(6):1059-60. PubMed ID: 17157592
[TBL] [Abstract][Full Text] [Related]
15. Clinical management of trichotillomania with bimatoprost.
Peabody T; Reitz S; Smith J; Teti B
Optom Vis Sci; 2013 Jun; 90(6):e167-71. PubMed ID: 23645373
[TBL] [Abstract][Full Text] [Related]
16. Successful use of bimatoprost in the treatment of alopecia of the eyelashes.
Zaheri S; Hughes B
Clin Exp Dermatol; 2010 Jun; 35(4):e161-2. PubMed ID: 19925481
[No Abstract] [Full Text] [Related]
17. The impact of ocular adverse effects in patients treated with topical prostaglandin analogs: changes in prescription patterns and patient persistence.
Zimmerman TJ; Hahn SR; Gelb L; Tan H; Kim EE
J Ocul Pharmacol Ther; 2009 Apr; 25(2):145-52. PubMed ID: 19284321
[TBL] [Abstract][Full Text] [Related]
18. Retrospective Evaluation of Topical Bimatoprost and Iris Pigmentation Change.
Zaleski-Larsen LA; Ruth NH; Fabi SG
Dermatol Surg; 2017 Dec; 43(12):1431-1433. PubMed ID: 28562438
[TBL] [Abstract][Full Text] [Related]
19. Unilateral trichomegaly induced by bimatoprost ophthalmic solution.
Hempstead N; Hempstead RW
J Drugs Dermatol; 2004; 3(5):571-2. PubMed ID: 15552614
[TBL] [Abstract][Full Text] [Related]
20. Effects of LATISSE (bimatoprost 0.03 per cent topical solution) on the ocular surface.
Bitton E; Courey C; Giancola P; Diaconu V; Wise J; Wittich W
Clin Exp Optom; 2017 Nov; 100(6):583-589. PubMed ID: 28122407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
